Sajulga, Annie Rose .
HRN: 03-75-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
AMPICILLIN 1GM (VIAL)
04/09/2025
04/15/2025
IV
2g
Q6
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes